CenExel Acquires iResearch
May 3, 2022
CenExel, a Salt Lake City–based clinical research site network, acquired iResearch, a multi-specialty clinical research site with locations in Decatur and Savannah, Georgia. The deal strengthens CenExel's CNS (psychiatry and neurology) and dermatology trial capabilities while expanding its patient reach in the Atlanta metro and throughout Georgia.
- Buyers
- CenExel
- Targets
- iResearch
- Sellers
- iResearch (co-founders Heather Beitz and Sara Castle)
- Industry
- Healthcare Services
- Location
- Georgia, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
CenExel Clinical Research Acquires California Neuroscience Research
January 10, 2022
Healthcare Services
CenExel Clinical Research, a Salt Lake City–based clinical research site network, has acquired California Neuroscience Research, a Los Angeles area neurology and psychiatry clinical research facility led by Dr. Tom Shiovitz. The acquisition strengthens CenExel's central nervous system (CNS) trial capabilities and expands its patient reach in the Los Angeles market.
-
CenExel Clinical Research Acquires CITrials
March 9, 2021
Healthcare Services
CenExel Clinical Research, a U.S.-based network of clinical research sites, has acquired CITrials, a Southern California clinical research firm operating three sites serving Los Angeles, Orange, and Riverside/San Bernardino counties. The acquisition expands CenExel's capacity and capabilities in psychiatric and neurological (CNS) research and enables greater integration with its other Southern California operations.
-
CenExel Acquires ForCare Clinical Research
August 4, 2021
Healthcare Services
CenExel Clinical Research has acquired Tampa-based ForCare Clinical Research, adding a dermatology- and immunology-focused clinical research site to its Centers of Excellence network. The addition strengthens CenExel's capabilities to conduct Phase I–IV trials across dermatology, immunology and other therapeutic areas and will integrate ForCare into CenExel's centralized operations and quality systems. Provident Healthcare Partners served as exclusive sell-side financial advisor to ForCare in the transaction.
-
CenExel Acquires Apex Innovative Sciences from Bison Capital
June 16, 2022
Healthcare Services
CenExel Clinical Research has acquired Apex Innovative Sciences, Inc. from Bison Capital Partners V, LP. The transaction adds Apex’s CNS-focused clinical research sites (including Collaborative Neuroscience Research and Hassman Research Institute) — five centers across California and New Jersey with substantial early‑phase and inpatient capacity — expanding CenExel’s neuroscience capabilities and geographic footprint.
-
CenExel Clinical Research Acquires Rocky Mountain Movement Disorders Center
January 11, 2022
Healthcare Services
CenExel Clinical Research, Inc. acquired the clinical research site operations of Rocky Mountain Movement Disorders Center (now CenExel RMCR), expanding CenExel's neurology/CNS trial capabilities and site network. Objective, Investment Banking & Valuation acted as exclusive sell-side advisor to Rocky Mountain Movement Disorders Center and the transaction will allow the center to leverage CenExel's centralized processes and network.
-
CenExel Clinical Research Acquires Advanced Memory Research Institute
August 19, 2021
Healthcare Services
CenExel Clinical Research, Inc. has acquired Advanced Memory Research Institute (CenExel AMRI), the largest Alzheimer's Disease clinical research site in the U.S. Northeast. The deal expands CenExel's CNS and Alzheimer's trial capabilities by integrating AMRI into its Centers of Excellence network; Provident Healthcare Partners served as exclusive sell-side financial advisor.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.